Literature DB >> 22131437

Current endovascular treatment options of dural venous sinus thrombosis: a review of the literature.

Nihar B Gala1, Nitin Agarwal, James Barrese, Chirag D Gandhi, Charles Joseph Prestigiacomo.   

Abstract

Dural venous sinus thrombosis, although relatively rare, has the propensity to cause potentially fatal conditions, such as stroke. This review presents the current endovascular treatment and management options for dural venous sinus thrombosis and provides current recommendations. Select databases were utilized for an exhaustive literature search with key search terms in efforts to obtain all relevant cases to endovascular treatment of dural venous sinus thrombosis. Recommendations for management options include initially the use of anticoagulation. For patients with a poor prognosis, local thrombolysis with urokinase or recombinant tissue plasminogen activator should be initiated. Ultimately, if the patient is not a good candidate for local or systemic thrombolysis, treatment via rheolytic thrombectomy should be employed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22131437     DOI: 10.1136/neurintsurg-2011-010117

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  10 in total

1.  Endovascular treatment of cerebral venous thrombosis: Contemporary multicenter experience.

Authors:  Maxim Mokin; Demetrius K Lopes; Mandy J Binning; Erol Veznedaroglu; Kenneth M Liebman; Adam S Arthur; Vinodh T Doss; Elad I Levy; Adnan H Siddiqui
Journal:  Interv Neuroradiol       Date:  2015-06-08       Impact factor: 1.610

2.  Cerebral venous sinuses thrombosis in both transverse sinus and torcula: Multistep endovascular treatment and stenting.

Authors:  G Cabral de Andrade; A Lesczynsky; V M Clímaco; E R Pereira; P O Marcelino; Aoc Franco; D F De Almeida
Journal:  Interv Neuroradiol       Date:  2016-10-27       Impact factor: 1.610

3.  Evaluation and management of a patient with possible cerebral venous thrombosis.

Authors:  Fernando Barinagarrementeria; Antonio Arauz
Journal:  Neurol Clin Pract       Date:  2014-10

4.  Solitaire FR device for treatment of dural sinus thrombosis.

Authors:  Bryan Anthony Pukenas; Monisha Kumar; Michael Stiefel; Michelle Smith; Robert Hurst
Journal:  BMJ Case Rep       Date:  2012-12-19

5.  Stenting for acute cerebral venous sinus thrombosis in the superior sagittal sinus.

Authors:  Hidemitsu Adachi; Yohei Mineharu; Tatsuya Ishikawa; Hirotoshi Imamura; Shiro Yamamoto; Kenichi Todo; Hiroshi Yamagami; Nobuyuki Sakai
Journal:  Interv Neuroradiol       Date:  2015-10-22       Impact factor: 1.610

6.  Endovascular treatment of acute thrombosis of cerebral veins and sinuses.

Authors:  Sergey Borisovich Yakovlev; Aleksei Vasilievich Bocharov; Ketevan Mikeladze; Sergey Surenovich Gasparian; Natalia Konstantinovna Serova; Alexander Romanovich Shakhnovich
Journal:  Neuroradiol J       Date:  2014-08-29

Review 7.  New Developments in the Pathophysiology, Workup, and Diagnosis of Dural Venous Sinus Thrombosis (DVST) and a Systematic Review of Endovascular Treatments.

Authors:  Sanjay Konakondla; Clemens M Schirmer; Fengwu Li; Xiaogun Geng; Yuchuan Ding
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

8.  Postpartum superior sagittal, left transverse sinus and right internal jugular vein thrombosis with left parietal infarct: A case report.

Authors:  Muhammad Naveed Ur Rehman; Dr Ubaid Khan; Ayesha Aslam
Journal:  Radiol Case Rep       Date:  2022-04-05

9.  Cerebral Venous Sinus Thrombosis is a Reversible Complication of Ulcerative Colitis.

Authors:  Hussain A Al Ghadeer; Sadeq A Alsalman; Jaafer Alobaid; Zainab I AlAbdi; Sultan S Aljereish; Shymaa Buhlaiqah; Maryam M Aljumah
Journal:  Cureus       Date:  2022-03-12

10.  A rare case of deep cerebral venous thrombosis secondary to traumatic epidural hematoma: Case report.

Authors:  Haiyan Zheng; Weilin Xu; Yili Chen; Shiying Gai; Gao Chen
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.